Click to read this study in The Lancet Oncology.
#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma
Mar 20, 2023
Advertisement
![PET and MRI Reveal Disability Correlation in MS via [11C]PIB](https://cdn.physiciansweekly.com/wp-content/uploads/2024/07/Spinal-Movement-Disorders.png)
Business of Medicine
Advertisement
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.